Head-to-head comparison
Ivy Rx vs Strut Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.
From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Limited public information on program details
Desk Score
The same molecule as a lozenge or an injection, each priced on its own page — the only place in this ranking where the needle is genuinely optional.
$129/mo (see conditions) sema · $149/mo (see conditions) tirz · Verified August 2026
Marked down on: FDA issued Strut Health, LLC dba Strut a warning letter in February 2026; the letter is public in FDA's warning-letter database
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Strut Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 77/100 (C+) for Ivy Rx. Ivy Rx still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Ivy Rx
77/100
C+
Strut Health
89/100
B+
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Ivy Rx | Strut Health |
|---|---|---|
| Semaglutide | From $175/molowest dose rung$175/mo (starting dose, compounded) | $129/mosee conditions$129/mo injectable (30-day supply on the product page; the auto-refill "as low as" badge prints the same $129, so no separate one-time price is shown; compounded) · $99/mo oral lozenge (30-day supply; same auto-refill shape) |
| Tirzepatide | From $275/molowest dose rung$275/mo (starting dose, compounded) | $149/mosee conditions$149/mo injectable (30-day supply on the product page; the auto-refill "as low as" badge prints the same $149, so no separate one-time price is shown; compounded) · $199/mo oral lozenge (30-day supply; same auto-refill shape) |
| Coverage | All 50 states | 49 states (not Arkansas) |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Yes |
| Best for | Mainstream telehealth GLP-1 access. | People whose real objection is the needle rather than the medicine, and who want every route priced before signing up. |
| Desk Score | 77/100C+ | 89/100B+ |
The verdict
Desk pick — Strut HealthStrut Health takes this head-to-head with the higher Desk Score, 89/100 (B+) against 77/100 (C+) for Ivy Rx. Ivy Rx still holds its ground where its strengths line up with yours.
Choose Ivy Rx if…
Mainstream telehealth GLP-1 access.
From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · All 50 states
Choose Strut Health if…
People whose real objection is the needle rather than the medicine, and who want every route priced before signing up.
$129/mo (see conditions) sema · $149/mo (see conditions) tirz · 49 states (not Arkansas)
FDAWarning letter issued to Strut Health, LLC dba Strut in February 2026. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Ivy Rx · Strut Health.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Ivy Rx
- CoreAge Rx vs Strut Health
- Ivy Rx vs Trimi
- Sesame Care vs Strut Health
- Elara Health and Wellness vs Ivy Rx
- BetterMe Rx vs Strut Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.